Informations générales (source: ClinicalTrials.gov)

NCT05473975 En recrutement IDF
Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker (BEERS)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
janvier 2023
juillet 2025
29 juin 2024
Early recanalization is a major prognostic factor in vascular accidents ischemic brain injury (AIC). The acute phase therapies of AIC aim to recanalization by intravenous thrombolysis and/or mechanical thrombectomy. Recanalization is identified immediately during thrombectomy by per-procedural arteriography. For the thrombolysis, only a performed MRI will validate the recanalization. This "proof of concept" study aims to identify an Electro-Encephalographic biomarker (EEG) of the recanalization in real time, the EEG being easy to set up. This biomarker will be sought during recanalization certified by thrombectomy in order to identify the window time for which the biomarker must be sought on the EEG. During this study, the identified EEG biomarker can be used to validate the recanalization during the intravenous thrombolysis in future studies

Etablissements

Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données
HOPITAL FONDATION A. DE ROTHSCHILD Michaël OBADIA En recrutement IDF 25/06/2024 13:22:18  Contacter

Critères

Tous
Inclusion Criteria:

- Patient over 18 years old

- Presenting a cerebral infarction with proximal occlusion of the sylvian artery
requiring thrombectomy

- No objection to participation in the study



- Pregnant or breastfeeding women

- Patient benefiting from legal protection

- Absence of affiliation to a social protection scheme

- Recent cranial surgery not allowing the installation of a scalp EEG